AGENT DESTINÉ À INHIBER L'EXPRESSION DE L'ARNM DE NPC1L1 ET/OU DE LIPG ET AGENT DESTINÉ À PRÉVENIR ET/OU TRAITER L'OBÉSITÉ

• 收藏
• 分享

专利权人:

LTD.;KOWA COMPANY

发明人:

MURAKAMI, TAKESHI,MURAKAMI, KENTARO,OHGIYA, TADAAKI,SHIBUYA, KIMIYUKI

申请号：

EP12854422

公开号：

EP2789347A4

申请日:

2012.11.28

申请国别(地区):

EP

年份:

2015

代理人:

摘要：

Provided is an agent for treating and/or preventing obesity. An agent for suppressing expression of NPC1L1 (Niemann-Pick disease, type C1, gene-like 1) and/or LIPG (Lipase, endothelial) mRNA, and an agent for preventing and/or treating obesity, each comprising, as an active ingredient, a compound having CETP inhibitory activity, or a salt thereof, or a solvate thereof.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/